Scinovex
article Open Access

Isoflavones in gynecology, non-conventional therapy

International Journal of Advanced Research in Medicine · 2020 · Vol. 2(2) · pp. 157–161
Sana Abd Al Hadi AbedRawaa Abdulraheem HasanZainab Naji Hashim

Abstract

Soy and its components, isoflavones such as genistein, daidzein, and ipriflavone are currently marketed by those who practice alternative medicine for the promotion and prevention of neoplastic, osteoporosis, climacteric and cardiovascular diseases. Different medical publications present studies carried out in order to confirm its pharmacological benefits in light of the scientific method. Although there is clear evidence of its effects when interacting with steroid receptors in the human body, recognized by entities such as the Food and Drugs Administration of the United States, controlled studies are still lacking to determine its real therapeutic impact; Biases in the populations analyzed must be improved and more studies dedicated to each of the isoflavone components separately in order to assess their own therapeutic spectrum.

Phytoestrogen effects and researchDaidzeinIsoflavonesGenisteinOsteoporosisMedicineClimactericSOY ISOFLAVONESTraditional medicineMenopauseIntensive care medicine
Citations
0
FWCI
0.00
field-weighted impact
References
41
Percentile
19%
vs. same field & year
References
Antioxidant and Antipromotional Effects of the Soybean Isoflavone Genistein
Experimental Biology and Medicine · 1995 · 512 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Isoflavones in gynecology, non-conventional therapy · Scinovex